Collegium Pharmaceutical Misses Q4 Earnings and Revenue Estimates

Collegium Pharmaceutical reported Non-GAAP EPS of $2.04, missing estimates by $0.10, and revenue of $205.4 million, which also missed expectations by $0.96 million.